{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:36:28Z","timestamp":1791333388621,"version":"4.3.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.clineuro.2024.108312","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T16:19:38Z","timestamp":1714493978000},"page":"108312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A systematic review and meta-analysis of major blood protein biomarkers that predict unfavorable outcomes in severe traumatic brain injury"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0227-4588","authenticated-orcid":false,"given":"Faraz","family":"Behzadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego D.","family":"Luy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Schaible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Zywiciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava M.","family":"Puccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand V.","family":"Germanwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clineuro.2024.108312_bib1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2018","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2024.108312_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105526","article-title":"Global outcome after traumatic brain injury in a prospective cohort","volume":"186","author":"Singh","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108312_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0976-3147.193543","article-title":"Outcome prediction after traumatic brain injury: comparison of the performance of routinely used severity scores and multivariable prognostic models","volume":"8","author":"Majdan","year":"2017","journal-title":"J. Neurosci. Rural Pr."},{"key":"10.1016\/j.clineuro.2024.108312_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6947-6-38","article-title":"Systematic review of prognostic models in traumatic brain injury","volume":"6","author":"Perel","year":"2006","journal-title":"BMC Med Inf. Decis. Mak."},{"issue":"8","key":"10.1016\/j.clineuro.2024.108312_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050165","article-title":"Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics","volume":"5","author":"Steyerberg","year":"2008","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.clineuro.2024.108312_bib6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(22)00218-6","article-title":"Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort study","volume":"21","author":"Helmrich","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2024.108312_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bas.2023.102735","article-title":"Blood biomarkers for traumatic brain injury: a narrative review of current evidence","volume":"4","author":"Hossain","year":"2024","journal-title":"Brain Spine"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108312_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/14737159.2018.1428089","article-title":"An update on diagnostic and prognostic biomarkers for traumatic brain injury","volume":"18","author":"Wang","year":"2018","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"Pt B","key":"10.1016\/j.clineuro.2024.108312_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuropharm.2018.08.004","article-title":"Pathophysiology and treatment of cerebral edema in traumatic brain injury","volume":"145","author":"Jha","year":"2019","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108312_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/neu.2005.22.83","article-title":"Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury","volume":"22","author":"Gabbita","year":"2005","journal-title":"J. Neurotrauma"},{"issue":"Pt 7","key":"10.1016\/j.clineuro.2024.108312_bib11","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/brain\/awn119","article-title":"Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"131","author":"Anderson","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108312_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/neu.2015.4333","article-title":"Increases of plasma levels of glial fibrillary acidic protein, tau, and amyloid beta up to 90 days after traumatic brain injury","volume":"34","author":"Bogoslovsky","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.clineuro.2024.108312_bib13","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.2147\/NDT.S125620","article-title":"Biomarkers in traumatic brain injury (TBI): a review","volume":"14","author":"Dadas","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108312_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.clineuro.2024.108312_bib15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3389\/fneur.2017.00652","article-title":"A systematic review of the usefulness of glial fibrillary acidic protein for predicting acute intracranial lesions following head trauma","volume":"8","author":"Luoto","year":"2017","journal-title":"Front Neurol."},{"issue":"23","key":"10.1016\/j.clineuro.2024.108312_bib16","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1089\/neu.2020.7140","article-title":"Point-of-care platform blood biomarker testing of glial fibrillary acidic protein versus S100 calcium-binding protein b for prediction of traumatic brain injuries: a transforming research and clinical knowledge in traumatic brain injury study","volume":"37","author":"Okonkwo","year":"2020","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.clineuro.2024.108312_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102785","article-title":"Blood biomarkers on admission in acute traumatic brain injury: relations to severity, CT findings and care path in the CENTER-TBI study","volume":"56","author":"Czeiter","year":"2020","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.clineuro.2024.108312_bib18","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1089\/neu.2016.4772","article-title":"Modeling the kinetics of serum glial fibrillary acidic protein, ubiquitin carboxyl-terminal hydrolase-L1, and S100B concentrations in patients with traumatic brain injury","volume":"34","author":"Welch","year":"2017","journal-title":"J. Neurotrauma"},{"issue":"8","key":"10.1016\/j.clineuro.2024.108312_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/neu.2014.3635","article-title":"Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging","volume":"32","author":"McMahon","year":"2015","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108312_bib20","first-page":"104","article-title":"Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase","volume":"69","author":"Honda","year":"2010","journal-title":"J. Trauma"},{"key":"10.1016\/j.clineuro.2024.108312_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.wneu.2015.11.055","article-title":"The Rotterdam Scoring System Can Be Used as an Independent Factor for Predicting Traumatic Brain Injury Outcomes","volume":"87","author":"Talari","year":"2016","journal-title":"World Neurosurg."},{"issue":"13","key":"10.1016\/j.clineuro.2024.108312_bib22","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1089\/neu.2018.6020","article-title":"Cost-effectiveness of biomarker screening for traumatic brain injury","volume":"36","author":"Su","year":"2019","journal-title":"J. Neurotrauma"},{"issue":"3","key":"10.1016\/j.clineuro.2024.108312_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3171\/2015.6.JNS15674","article-title":"Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial","volume":"125","author":"Raheja","year":"2016","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2024.108312_bib24","article-title":"Temporal profiles of P-Tau, T-Tau, and P-Tau:Tau ratios in cerebrospinal fluid and blood from moderate-severe traumatic brain injury patients and relationship to 6-12 month global outcomes","author":"Rubenstein","year":"2023","journal-title":"J. Neurotrauma"},{"issue":"20","key":"10.1016\/j.clineuro.2024.108312_bib25","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1089\/neu.2019.6375","article-title":"A serum protein biomarker panel improves outcome prediction in human traumatic brain injury","volume":"36","author":"Thelin","year":"2019","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108312_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/neu.2013.3040","article-title":"Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein","volume":"31","author":"Diaz-Arrastia","year":"2014","journal-title":"J. Neurotrauma"},{"issue":"9","key":"10.1016\/j.clineuro.2024.108312_bib27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamaneurol.2017.0655","article-title":"Comparing plasma phospho tau, total tau, and phospho tau-total tau ratio as acute and chronic traumatic brain injury biomarkers","volume":"74","author":"Rubenstein","year":"2017","journal-title":"JAMA Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.clineuro.2024.108312_bib28","first-page":"S23","article-title":"External Validation of the Rotterdam computed tomography score in the prediction of mortality in severe traumatic brain injury","volume":"8","author":"Charry","year":"2017","journal-title":"J. Neurosci. Rural Pract."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108312_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/TA.0000000000002706","article-title":"Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury","volume":"89","author":"Anderson","year":"2020","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.clineuro.2024.108312_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bas.2023.102727","article-title":"Intracranial dynamics biomarkers at traumatic cerebral vasospasm","volume":"4","author":"Trofimov","year":"2024","journal-title":"Brain Spine"},{"issue":"8","key":"10.1016\/j.clineuro.2024.108312_bib31","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1089\/neu.2017.5182","article-title":"Blood-based protein biomarkers for the management of traumatic brain injuries in adults presenting to emergency departments with mild brain injury: a living systematic review and meta-analysis","volume":"38","author":"Mondello","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.clineuro.2024.108312_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.peptides.2014.07.016","article-title":"Comparison of the performances of copeptin and multiple biomarkers in long-term prognosis of severe traumatic brain injury","volume":"60","author":"Zhang","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.clineuro.2024.108312_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.wneu.2015.10.066","article-title":"Glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 as outcome predictors in traumatic brain injury","volume":"87","author":"Takala","year":"2016","journal-title":"World Neurosurg."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724001999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724001999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:50:50Z","timestamp":1718362250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846724001999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":33,"alternative-id":["S0303846724001999"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108312","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of major blood protein biomarkers that predict unfavorable outcomes in severe traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108312"}}